View Exam | PowerPak

1. According to the ACTT-1 pivotal trial, which group of patients benefited the most from remdesivir?

A. All included patients benefitted equally B. Patients not receiving oxygen C. Patients on oxygen not requiring mechanical ventilation or ECMO D. Patients receiving mechanical ventilation or ECMO

2. Monty is a 74-year-old man with diffuse B cell lymphoma undergoing R-CHOP chemotherapy. He has been hospitalized with COVID-19 for two days and he now requires noninvasive ventilation. Which of the following combinations is appropriate for him, according to the NIH recommendations?

A. Dexamethasone, remdesivir, and baricitinib B. Dexamethasone, baricitinib, and tocilizumab C. Dexamethasone and remdesivir D. Remdesivir and tocilizumab

3. According to the NIH recommendations, patients who are critically ill with COVID-19 (requiring invasive MV or ECMO) but without evidence of VTE should receive:

A. No anticoagulation therapy B. Prophylactic dose of anticoagulation C. Therapeutic dose of anticoagulation D. No anticoagulant recommendations are provided for critically ill patients

4. All of the following are included in NIH treatment recommendations for people hospitalized because of COVID-19 except:

A. Baricitinib B. Remdesivir C. Tocilizumab D. Molnupiravir

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the ACTT-1 pivotal trial, which group of patients benefited the most from remdesivir?

2. Monty is a 74-year-old man with diffuse B cell lymphoma undergoing R-CHOP chemotherapy. He has been hospitalized with COVID-19 for two days and he now requires noninvasive ventilation. Which of the following combinations is appropriate for him, according to the NIH recommendations?

3. According to the NIH recommendations, patients who are critically ill with COVID-19 (requiring invasive MV or ECMO) but without evidence of VTE should receive:

4. All of the following are included in NIH treatment recommendations for people hospitalized because of COVID-19 except:

« Return to Activity

Maintenance is scheduled for 8/7/2023 7:00 AM EST - 8:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. According to the ACTT-1 pivotal trial, which group of patients benefited the most from remdesivir?

2. Monty is a 74-year-old man with diffuse B cell lymphoma undergoing R-CHOP chemotherapy. He has been hospitalized with COVID-19 for two days and he now requires noninvasive ventilation. Which of the following combinations is appropriate for him, according to the NIH recommendations?

3. According to the NIH recommendations, patients who are critically ill with COVID-19 (requiring invasive MV or ECMO) but without evidence of VTE should receive:

4. All of the following are included in NIH treatment recommendations for people hospitalized because of COVID-19 except:

« Return to Activity

Customers who Purchased
this Activity also Purchased